Home▸Lung Cancer Treatment▸ALK-Rearrangement Targeted Therapy (Alectinib) Simulator

🫁 ALK-Rearrangement Targeted Therapy (Alectinib) Simulator

The model demonstrates the action of alectinib in ALK-positive non-small cell lung cancer, showing inhibition of the EML4-ALK fusion oncogene and drug penetration through the blood-brain barrier.

Lung Cancer Treatment2DModerate60 FPS

⚙ Under the hood

The model demonstrates the action of alectinib in ALK-positive non-small cell lung cancer, showing inhibition of the EML4-ALK fusion oncogene and drug penetration through the blood-brain barrier.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install